The National Prescribing Centre has published four patient decision aids (PDAs) that can be used during consultations to help patients decide whether they want to take antiviral medication for the treatment of influenza like illness.
The four PDAs cover different patient populations as follows:
- At-risk children and adolescents
- Otherwise healthy children younger than 13 years
- At-risk adults
- Otherwise healthy adults (13 to 64 years)
PDAs aim to present risk and benefit information visually to patients in order to allow them to make a decision to accept or refuse a specific treatment. They may prove useful in the coming months if the expected second wave of swine 'flu (H1N1) occurs.
Action: Clinicians should be aware of the availability of these PDAs and make use of them where they will aid patient decision making.
|« Generic topiramate||Tafluprost launched »|